Epigenetic differences in human cartilage between mild and severe OA

Journal of Orthopaedic Research

Volumn 32, Issue 12, 2014, Pages 1636-1645

  Moazedi Fuerst, Florentine C ^a   Hofner, Manuela ^b   Gruber, Gerald ^a   Weinhaeusel, Andreas ^b   Stradner, Martin H ^a   Angerer, Hannes ^a   Peischler, Daniela ^a   Lohberger, Birgit ^a   Glehr, Mathias ^a   Leithner, Andreas ^a   Sonntagbauer, Markus ^b   Graninger, Winfried B ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b AIT AUSTRIAN INSTITUTE OF TECHNOLOGY   (Austria)

Author keywords

Methylation; Osteoarthritis; Whole genome array

Indexed keywords

GENOMIC DNA; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CARTILAGE; CLINICAL ARTICLE; DISEASE SEVERITY; DNA EXTRACTION; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; FEMALE; GENE ONTOLOGY; GENE TARGETING; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; OSTEOARTHRITIS; PROTEIN DOMAIN; TOTAL KNEE REPLACEMENT; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; WNT SIGNALING PATHWAY;

AGED; BONE MORPHOGENETIC PROTEIN 7; CARTILAGE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; MIDDLE AGED; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TRANSFORMING GROWTH FACTOR BETA; WNT SIGNALING PATHWAY;

EID: 84911447416     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22722     Document Type: Article

References (50)

1. Aigner T, McKenna L. 2002. Molecular pathology and pathobi-ology of osteoarthritic cartilage. Cell Mol Life Sci 59:5-18.
2. Schroeppel JP, Crist JD, Anderson HC, et al. 2011. Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. Histol Histopathol 26:377-394.
3. Lories RJ, Corr M, Lane NE. 2013. To Wnt or not to Wnt: the bone and joint health dilemma. Nat Rev Rheumatol 9:328-339. 10.1038/nrrheum.2013.25
4. Blaney Davidson EN, van der Kraan PM, van den Berg WB. 2007. TGF-beta and osteoarthritis. Osteoarthritis Cartilage 15:597-604.
5. DeLise AM, Fischer L, Tuan RS. 2000. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 8:309-334.
6. van Beuningen HM, Glansbeek HL, van der Kraan PM, et al. 2000. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 8:25-33.
7. van der Kraan PM, Goumans MJ, Blaney Davidson, et al. 2012. Age-dependent alteration of TGF-beta signalling in osteoarthritis. Cell Tissue Res 347:257-265. 10.1007/s00441-011-1194-6
8. Mill J, Petronis A. 2007. Molecular studies of major depressive disorder: the epigenetic perspective. Mol Psychiatry 12:799-814.
9. Roach HI, Yamada N, Cheung KS, et al. 2005. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demeth-ylation of specific CpG sites in the promoter regions. Arthritis Rheum 52:3110-3124.
10. Iliopoulos D, Malizos KN, Tsezou A. 2007. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 66:1616-1621.
11. Roach HI, Aigner T. 2007. DNA methylation in osteoarthritic chondrocytes: a new molecular target. Osteoarthritis Cartilage 15:128-137.
12. Camplejohn KL, Allard SA. 1988. Limitations of safranin 'O' staining in proteoglycan-depleted cartilage demonstrated with monoclonal antibodies. Histochemistry 89:185-188.
13. Pritzker KP, Gay S, Jimenez SA, et al. 2006. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14:13-29.
14. Weinhaeusel A, Thiele S, Hofner M, et al. 2008. PCR-based analysis of differentially methylated regions of GNAS enables convenient diagnostic testing of pseudohypopara-thyroidism type Ib. Clin Chem 54:1537-1545.
15. Simon R, Lam A, Li MC, et al. 2007. Analysis of Gene Expression Data Using BRB-Array Tools. Cancer Inform 3:11-17.
16. Wright GW, Simon RM. 2003. A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19:2448-2455.
17. Zhang B, Kirov S, Snoddy J, 2005. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33:W741-748.
18. Kanehisa M, Goto S, Kawashima S, et al. 2004. The KEGG resource for deciphering the genome. Nucleic Acids Res 32: D277-280.
19. van Beuningen HM, van der Kraan PM, Arntz OJ, et al. 1994. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteo-phyte formation in the murine knee joint. Lab Invest 71: 279-290.
20. Jones SW, Brockbank SM, Mobbs ML, et al. 2006. The orphan G-protein coupled receptor RD C1: evidence for a role in chondrocyte hypertrophy and articular cartilage matrix turnover. Osteoarthritis Cartilage 14:597-608.
21. Richardson B. 2003. Impact of aging on DNA methylation. Ageing Res Rev 2:245-261.
22. Aigner T, Rose J, Martin J, et al. 2004. Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res 7:134-145.
23. Loeser RF, Im HJ, Richardson B, et al. 2009. Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis Cartilage 17: 513-517.
24. Nishimura R, Hata K, Matsubara T, et al. 2012. Regulation of bone and cartilage development by network between BMP signalling and transcription factors. J Biochem 151:247-254. 10.1093/jb/mvs004
25. van der Kraan PM, Blaney Davidson EN, van den Berg WB. 2010. Bone morphogenetic proteins and articular cartilage: to serve and protect or a wolf in sheep clothing's? Osteoar-thritis Cartilage 18:735-741.
26. Blaney Davidson EN, Vitters EL, van Lent PL, et al. 2007. Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling. Arthritis Res Ther 9:R102.
27. Chubinskaya S, Hurtig M, Rueger DC. 2007. OP-1/BMP-7 in cartilage repair. Int Orthop 31:773-781.
28. Serra R, Johnson M, Filvaroff EH, et al. 1997. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139:541-552.
29. Zhen G, Wen C, Jia X, et al. 2013. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 19:704-712. 10.1038/nm.3143
30. Venkatesan JK, Rey-Rico A, Schmitt G, et al. 2013. rAAV-mediated overexpression of TGF-beta stably restructures human osteoarthritic articular cartilage in situ. J Transl Med 11:211.
31. Li TF, Gao L, Sheu TJ, et al. 2010. Aberrant hypertrophy in Smad3-deficient murine chondrocytes is rescued by restoring transforming growth factor beta-activated kinase 1/activat-ing transcription factor 2 signaling: a potential clinical implication for osteoarthritis. Arthritis Rheum 62:2359-2369.
32. Pombo-Suarez M, Castano-Oreja MT, Calaza M, et al. 2009. Differential upregulation of the three transforming growth factor beta isoforms in human osteoarthritic cartilage. Ann Rheum Dis 68:568-571.
33. Pujol JP, Chadjichristos C, Legendre F, et al. 2008. Inter-leukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism. Connect Tissue Res 49:293-297.
34. Wotton D, 2012. TGF-beta drives DNA demethylation. Mol Cell 46:556-557. 10.1016/j.molcel.2012.05.031.
35. Blom AB, van Lent PL, van der Kraan PM, et al. 2010. To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapy. Curr Drug Targets 11:620-629.
36. Church V, Nohno T, Linker C, et al. 2002. Wnt regulation of chondrocyte differentiation. J Cell Sci 115:4809-4818.
37. Derfoul A, Carlberg AL, Tuan RS, et al. 2004. Differential regulation of osteogenic marker gene expression by Wnt-3a in embryonic mesenchymal multipotential progenitor cells. Differentiation 72:209-223.
38. Hopwood B, Tsykin A, Findlay DM, et al. 2007. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. Arthritis Res Ther 9:R100.
39. Hwang SG, Ryu JH, Kim IC, et al. 2004. Wnt-7a causes loss of differentiated phenotype and inhibits apoptosis of articular chondrocytes via different mechanisms. J Biol Chem 279:26597-26604.
40. Dong YF, Soung do Y, Schwarz EM, et al. 2006. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 208:77-86.
41. Soung do Y, Dong Y, Wang Y, et al. 2007. Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation. J Bone Miner Res 22: 1260-1270.
42. Sato S, Kimura A, Ozdemir J, et al. 2008. The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease. Arthritis Rheum 58:2764-2775.
43. Stricker S, Fundele R, Vortkamp A, et al. 2002. Role of Runx genes in chondrocyte differentiation. Dev Biol 245: 95-108.
44. Murata M, Trahan C, Hirahashi J, et al. 2003. Intracellular interleukin-1 receptor antagonist in osteoarthritis chondro-cytes. Clin Orthop Relat Res (409):285-295.
45. Kouri JB, Lavalle C. 2006. Do chondrocytes undergo "activation" and "transdifferentiation" during the pathogenesis of osteoarthritis? A review of the ultrastructural and immuno-histochemical evidence. Histol Histopathol 21:793-802.
46. Wallis GA. 1996. Bone growth: coordinating chondrocyte differentiation. Curr Biol 6:1577-1580.
47. Goldring MB. 2000. The role of the chondrocyte in osteoar-thritis. Arthritis Rheum 43:1916-1926.
48. Fernandez-Tajes J, Soto-Hermida A, Vazquez-Mosquera ME, et al. 2014. Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann Rheum Dis 73:668-677.
49. Hashimoto K, Otero M, Imagawa K, et al. 2013. Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1beta (IL1B) genes in chondro-cytes depends on methylation of specific proximal promoter CpG sites. J Biol Chem 288:10061-10072.
50. Joosten LA, Netea MG, Kim SH, et al. 2006. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 103:3298-3303.